Identification of a pathogenicity island required for Salmonella survival in host cells.

We have identified a region unique to the Salmonella typhimurium chromosome that is essential for virulence in mice. This region harbors at least three genes: two (spiA and spiB) encode products that are similar to proteins found in type III secretion systems, and a third (spiR) encodes a putative regulator. A strain with a mutation in spiA was unable to survive within macrophages but displayed wild-type levels of epithelial cell invasion. The culture supernatants of the spi mutants lacked a modified form of flagellin, which was present in the supernatant of the wild-type strain. This suggests that the Spi secretory apparatus exports a protease, or a protein that can alter the activity of a secreted protease. The "pathogenicity island" harboring the spi genes may encode the virulence determinants that set Salmonella apart from other enteric pathogens.

Epitope-specific tolerance induction with an engineered immunoglobulin.

Isologous and heterologous immunoglobulins have been shown to be extremely effective as tolerogenic carriers for nearly 30 years. The efficacy of these proteins is due in part to their long half-life in vivo, as well as their ability to crosslink surface IgM with Fc receptors. The concept of using IgG as a carrier molecule to induce unresponsiveness in the adult immune system has been exploited for simple haptens, such as nucleosides, as well as for peptides. To further evaluate the in vivo potential of these molecules for inducing tolerance to a defined epitope, we have engineered a fusion protein of mouse IgG1 with the immunodominant epitope 12-26 from bacteriophage lambda cI repressor protein. This 15-mer, which contains both a B-cell and T-cell epitope, has been fused in-frame to the N terminus of a mouse heavy chain IgG1 construct, thus creating a "genetic hapten-carrier" system. We describe a novel in vitro and in vivo experimental system for studying the feasibility of engineered tolerogens, consisting of a recombinant flagellin challenge antigen and a murine IgG1 tolerogen, both expressing the lambda repressor epitope 12-26. Herein, we show that peptide-grafted IgG molecules injected i.v., or expressed by transfected, autologous B cells, can efficiently modulate the cellular and humoral immune responses to immunodominant epitopes. This model displays the feasibility of "tailor-designing" immune responses to whole antigens by selecting epitopes for either tolerance or immunity.

Zeitschrift für Immunitätsforschung, experimentelle und klinische Immunologie.

Mode of access: Internet.

Different routes to pure food allergens: extraction, recombinant techniques and total chemical synthesis for obtaining the plant-food pan-allergen LTP

La richiesta di allergeni puri è in continuo aumento per scopi diagnostici, come standard per metodi di rilevamento e di quantificazione, per l'immunoterapia e per lo studio a livello molecolare dei meccanismi delle reazioni allergiche, al fine di facilitare lo sviluppo di possibili cure. In questa tesi di dottorato sono descritte diverse strategie per l’ottenimento di forme pure di non-specific Lipid Transfer Proteins (nsLTPs), le quali sono state riconosciute essere rilevanti allergeni alimentari in molti frutti e verdure comunemente consumati e sono state definite come modello di veri allergeni alimentari. Una LTP potenzialmente allergenica, non nota in precedenza, è stata isolata dalle mandorle, mentre una LTP dall’allergenicità nota contenuta nelle noci è stata prodotta mediante tecniche di DNA ricombinante. Oltre a questi approcci classici, metodi per la sintesi chimica totale di proteine sono stati applicati per la prima volta alla produzione di un allergene, utilizzando Pru p 3, la LTP prototipica e principale allergene della pesca nell'area mediterranea, come modello. La sintesi chimica totale di proteinepermette di controllarne completamente la sequenza e di studiare la loro funzione a livello atomico. La sua applicazione alla produzione di allergeni costituisce perciò un importante passo avanti nel campo della ricerca sulle allergie alimentari. La proteina Pru p 3 è stata prodotta nella sua intera lunghezza e sono necessari solo due passaggi finali di deprotezione per ottenere il target nella sua forma nativa. Le condizioni sperimentali per tali deprotezioni sono state messe a punto durante la produzione dei peptidi sPru p 3 (1-37) e sPru p 3 (38-91), componenti insieme l'intera proteina. Tecniche avanzate di spettrometria di massa sono state usate per caratterizzare tutti i composti ottenuti, mentre la loro allergenicità è stata studiata attraverso test immunologici o approcci in silico.

Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4 roles for cd14, lps-binding protein, and md2 as targets for specificity of inhibition

The generation of reactive oxygen species is a central feature of inflammation that results in the oxidation of host phospholipids. Oxidized phospholipids, such as 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (OxPAPC), have been shown to inhibit signaling induced by bacterial lipopeptide or lipopolysac-charide (LPS), yet the mechanisms responsible for the inhibition of Toll-like receptor (TLR) signaling by OxPAPC remain incompletely understood. Here, we examined the mechanisms by which OxPAPC inhibits TLR signaling induced by diverse ligands in macrophages, smooth muscle cells, and epithelial cells. OxPAPC inhibited tumor necrosis factor- production, IB degradation, p38 MAPK phosphorylation, and NF-B-dependent reporter activation induced by stimulants of TLR2 and TLR4 (Pam3CSK4 and LPS) but not by stimulants of other TLRs (poly(I·C), flagellin, loxoribine, single-stranded RNA, or CpG DNA) in macrophages and HEK-293 cells transfected with respective TLRs and significantly reduced inflammatory responses in mice injected subcutaneously or intraperitoneally with Pam3CSK4. Serum proteins, including CD14 and LPS-binding protein, were identified as key targets for the specificity of TLR inhibition as supplementation with excess serum or recombinant CD14 or LBP reversed TLR2 inhibition by OxPAPC, whereas serum accessory proteins or expression of membrane CD14 potentiated signaling via TLR2 and TLR4 but not other TLRs. Binding experiments and functional assays identified MD2 as a novel additional target of OxPAPC inhibition of LPS signaling. Synthetic phospholipid oxidation products 1-palmitoyl-2-(5-oxovaleryl)-sn-glycero-3-phosphocholine and 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine inhibited TLR2 signaling from 30 µM. Taken together, these results suggest that oxidized phospholipid-mediated inhibition of TLR signaling occurs mainly by competitive interaction with accessory proteins that interact directly with bacterial lipids to promote signaling via TLR2 or TLR4.

Genregulation in der Drosophila Spermatogenese am Beispiel der Mst(3)CGP-Genfamilie

In dieser Dissertation wird die Rolle des zentralen Kontrollelementes TCE auf unterschiedlichen Ebenen der Genexpression untersucht. Das TCE verhindert die Translation prämeiotisch gebildeter mRNAs in der Spermatogenese von Drosophila bis zu einem späten postmeiotischen Stadium. Gleichzeitig provoziert es Transkriptionsaktivität. Das TCE wurde zunächst in einer kleinen Genfamilie identifiziert und am Beispiel des Gens Mst87F detaillierter untersucht. In EMSA-Experimenten wurde die Komplexbildung mit regulatorischen Proteinen aus Proteinextrakten des Hodengewebes am TCE der Mst87F mRNA nachgewiesen. Massenspektrometrische Analysen ergaben u.a. die Kandidatenproteine Exuperantia (Exu), dFmr1 und CG3213. Die Komplexbildung an einem zweiten Mitglied der Genfamilie - Mst98Ca -, welches sich in der Genstruktur und dem Proteinaufbau von Mst87F unterscheidet, belegt die Allgemeingültigkeit dieser Interaktion. Beim Einsatz von veränderten TCE-Sequenzen ergibt sich ein abweichendes Erscheinungsbild der Komplexe, was mit dem Verlust der Funktion korreliert. Auch die Komplexbildung mit den rekombinanten Proteinen von exuperantia und dfmr1 erfolgt an beiden RNAs in gleicher Weise. In Kombination wird ein stärkerer Shift erzeugt. In einer Exu-defizienten Mutante beobachtet man drastische Veränderungen in der Lokalisation von einem Mst87F-GFP- bzw. CG3213-GFP-Fusionsprotein. Analysen mittels der qPCR zeigen eine drastische Verringerung der Mst87F mRNA Menge. Beides lässt vermuten, dass das Fehlen von Exu bereits in frühen Stadien zu molekularen Defekten führt. Um die Translationskontrolle zu umgehen, wurden Transgene mit einer IRES (aus dem Gen reaper) an verschiedenen Positionen des 5'UTRs erzeugt. Die erwartete Translationsinitiation durch die IRES blieb aus. Northern- und qPCR-Analysen zeigen eine starke Reduktion des mRNA-Niveaus. Somit kann aufgrund der drastischen Deregulation auf Transkriptionsebene der Effekt auf die Translationskontrolle nicht mehr analysiert werden. Überraschenderweise wurden durch die Verwendung einer anderen IRES (aus der Genkassette CG31311) die Expressionscharakteristika des Ursprungsgens auf Mst87F übertragen. Das Fusionsprotein lässt sich plötzlich in den Ommatidien der Komplexaugen nachweisen. Da aus früheren Arbeiten bereits eine Rolle des TCE auf Transkriptionsebene nachgewiesen ist, wurde die Komplexbildung auf Mst87F-DNA-Fragmente mit TCE ausgedehnt. Analysen unter Verwendung der rekombinanten Proteine Exu und dFmr1 verliefen negativ. Daraufhin sollten massenspektrometrische Experimente neue Kandidaten für regulatorische Proteine auf DNA-Ebene identifizieren. Von vier weiteren Kandidaten zeigen zwei unter RNAi-Einfluß komplette Sterilität und starke Defekte in der Spermienentwicklung.

The impact and control of malignant catarrhal fever in Tanzania

Malignant Catarrhal Fever (MCF), an often-lethal infectious disease, presents as a variable complex of lesions in susceptible ungulate species. The disease is caused by a -herpesvirus following transmission from an inapparent carrier host. Two major epidemiological forms exist: wildebeest-associated MCF (WA-MCF), in which the virus is transmitted to susceptible species by wildebeest calves less than approximately four months of age, and sheepassociated MCF (SA-MCF) in which the virus is spread by sheep (primarily adolescents). Due to the lack of an in-vitro propagation system for the causative agent of the more economically significant SA-MCF, and with the expectation that cross-protective immunity may be provided, vaccine development has focused on the more easily propagated alcelaphine herpesvirus-1 (AlHV-1) that causes WA-MCF. In 2008 a direct viral challenge trial showed that a novel vaccine, employing an attenuated AlHV-1 (atAlHV-1) `C5000 virus strain, protected British Friesian-Holstein (FH) cattle against an intranasal challenge with virulent AlHV-1 `C5000 virus. For cattle keeping people living near wildebeest calving areas in sub-Saharan Africa an effective vaccine would have value as it would release them from the costly annual disease avoidance strategy of having to move their herds away from the oncoming wildebeest. On the other hand, an effective vaccine will release herd owners from the need to avoid MCF, allowing them to graze their cattle alongside wildebeest on the highly nutritious pastures of the calving areas. As such conservationists have raised concerns that the development of a vaccine might lead to detrimental grazing competition. The principle objective of this study was to test the novel vaccine on Tanzanian shorthorn zebu cross cattle (SZC).We did this firstly using a natural challenge field trial (Chapter Two) which demonstrated that immunisation with the atAlHV-1 vaccine was well tolerated and induced an oro-nasopharyngeal AlHV-1-specific and -neutralising antibody response. This resulted in an immunity in SZC cattle that was partially protective and reduced naturally transmitted infection by 56%. We also demonstrated that non-fatal infections occurred with a much higher frequency than previously thought. Because the calculated efficacy of the vaccine was less than that seen in British FH cattle we wanted to determine whether host factors, particular to SZC cattle, had impacted the outcomes of the field trial. To do this we repeated the 2008 direct viral challenge trial using SZC cattle (Chapter Four). During this trial we also investigated whether the recombinant bacterial flagellin monomer (FliC), when used as an adjuvant, might improve the vaccine’s efficacy. The findings from this trial indicated that direct challenge with pathogenic AlHV-1 is effective at inducing MCF in SZC cattle and that FliC is not an appropriate adjuvant for this vaccine. Furthermore, with less control group cattle dying of MCF than expected we speculate that SZC cattle may have a degree of resistance to MCF that affords them protection from infection and developing fatal disease. In Chapter Three we investigated aspects of the epidemiology of MCF, specifically whether wildebeest placenta, long implicated by Maasai cattle owners as a source of MCF, might play a role in viral transmission. Additionally, through comparative sequence analysis, at two specific genes (A9.5 and ORF50) of wild-type and atAlHV-1, we investigated whether the `C5000 strain, the source of which was taken from Africa more than 40 years ago, was appropriate for vaccine development. The detection of AlHV-1 virus in approximately 50% of placentae indicated that infection can occur in-utero and that this tissue might play a role in disease transmission. And, despite describing three new alleles of the A9.5 gene (supporting previous evidence that this gene is polymorphic and encodes a secretory protein with interleukin-4 as the major homologue), the observation that the most frequently detected haplotypes, in both wild-type and attenuated AlHV-1, were identical suggests that AlHV-1 has a slow molecular clock and that the attenuated strain was appropriate for vaccine development. In Chapter Five we present the first quantitative assessment of the annual MCF avoidance costs that Maasai pastoralists incur. In particular we estimated that as a result of MCF avoidance 64% of the total daily milk yield during the MCF season was not available to be used by the 81% of the family unit remaining at the permanent boma. This represents an upper-bound loss of approximately 8% of a household0s annual income. Despite these considerable losses we concluded that, given an incidence of fatal MCF in cattle living in wildebeest calving areas of 5% to 10%, if herd owners were to stop trying to avoid MCF by allowing their cattle to graze alongside wildebeest, any gains made through increased availability of milk, improved body condition and reduced energy demands would be offset by an increase in MCF-incidence. With the development of an effective vaccine, however, this alternative strategy might become optimal. The overall conclusion we draw therefore is that, despite the substantial costs incurred each year avoiding MCF, the partial protection afforded by the novel vaccine strategy is not sufficient to warrant a wholesale change in disease avoidance strategy. Nonetheless, even the partial protection provided by this vaccine could be of value to protect animals that cannot be moved, for example where some of the herd remain at the boma to provide milk or where land-use changes make traditional disease avoidance difficult. Furthermore, the vaccine may offer a feasible solution to some of the current land-use challenges and conflicts, providing a degree of protection to valuable livestock where avoidance strategies are not possible, but with less risk of precipitating the potentially damaging environmental consequences, such as overgrazing of highly nutritious seasonal pastures, that might result if herd owners decide they no longer need to avoid wildebeest.

Applicazione di tecniche untarget molecolari e chimiche per la ricerca di allergeni vegetali in alimenti

I frutti secchi ed i semi commestibili hanno comprovati benefici per la salute, essendo il loro consumo relazionato con la riduzione del rischio di malattie croniche. Tuttavia, questi alimenti hanno un elevato potenziale allergico per una parte della popolazione mondiale. A causa del fatto che le allergie alimentari sono in aumento, diventa importante conoscere tutti i componenti presenti in un alimento, anche se in tracce. Il Regolamento UE n°1169/2011 ha normalizzato le leggi sull’etichettatura delle sostanze che causano allergie ed intolleranze alimentari. Di conseguenza, vi è l'urgente necessità di metodi specifici e affidabili in grado di rilevare allergeni negli alimenti che permettano di garantire la sicurezza alimentare e la conformità delle etichette, migliorando così la vita dei consumatori allergici. Sebbene le tecniche immunologiche siano più specifiche per l’identificazione di proteine allergeniche, le tecniche basate sul DNA sono più adatte per matrici alimentari molto complesse o nel caso di alimenti che hanno subito numerosi processi di trasformazione, mostrandosi come metodi alternativi affidabili. L’obiettivo di questo lavoro di tesi è stato quello di sviluppare una metodica per il rilevamento di specie allergeniche vegetali (frutta a guscio e semi commestibili) in matrici alimentari usando la tecnica del DNA Barcoding e la tecnica della Real-Time PCR. I vantaggi di queste tecniche sono, oltre alla necessità di quantità minime di campione, la possibilità di identificare varie specie allergeniche in simultaneo, anche dopo che queste abbiano subito processi di lavorazione. Si è inoltre fatta un’analisi fingerprinting dei composti volatili su matrici alimentari attraverso il gascromatografo HERACLES II. Le metodiche sviluppate possono fungere come metodi di screening veloci ed affidabili nella riduzione di possibili contaminazioni dei prodotti alimentari, rilevando la presenza o confermando l'assenza di allergeni.